×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MURA – mural oncology plc - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MURA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
04:15 pm
mura
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
Low
Report
Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
11/13
07:00 am
mura
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
Neutral
Report
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
11/11
08:10 am
mura
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Mural Oncology plc (NASDAQ: MURA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
11/11
07:00 am
mura
Mural Oncology to Participate in Two Upcoming Investor Conferences
Low
Report
Mural Oncology to Participate in Two Upcoming Investor Conferences
11/7
04:15 pm
mura
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Medium
Report
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/4
04:15 pm
mura
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/17
08:55 am
mura
Mural Oncology plc (NASDAQ: MURA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.
Medium
Report
Mural Oncology plc (NASDAQ: MURA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $18.00 price target on the stock.
10/7
07:00 am
mura
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Medium
Report
Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
06:02 am
mura
Form EFFECT Mural Oncology plc
Neutral
Report
Form EFFECT Mural Oncology plc
11/14
05:16 pm
mura
Form SC 13G/A Mural Oncology plc Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G/A Mural Oncology plc Filed by: ARMISTICE CAPITAL, LLC
11/14
03:19 pm
mura
Form SCHEDULE 13G Mural Oncology plc Filed by: Solas Capital Management, LLC
Low
Report
Form SCHEDULE 13G Mural Oncology plc Filed by: Solas Capital Management, LLC
11/14
12:01 pm
mura
Form SCHEDULE 13G/A Mural Oncology plc Filed by: ACORN BIOVENTURES, L.P.
Low
Report
Form SCHEDULE 13G/A Mural Oncology plc Filed by: ACORN BIOVENTURES, L.P.
11/13
07:06 am
mura
Form 10-Q Mural Oncology plc For: Sep 30
Neutral
Report
Form 10-Q Mural Oncology plc For: Sep 30
11/13
07:04 am
mura
Form 8-K Mural Oncology plc For: Nov 13
Neutral
Report
Form 8-K Mural Oncology plc For: Nov 13
11/12
03:53 pm
mura
Form SC 13G/A Mural Oncology plc Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Mural Oncology plc Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: